Rheumatoid Arthritis Personalisation
The tailor-made approach is based on autoantibody status, early glucocorticoid response, and early filgotinib response. The personalised strategy uses clinically available parameters rather than omics-based profiling.
1 sources - 4 claims
The tailor-made approach is based on autoantibody status, early glucocorticoid response, and early filgotinib response. The personalised strategy uses clinically available parameters rather than omics-based profiling.